Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer

BACKGROUND: Primary cytoreduction followed by platinum based chemotherapy is the primary treatment for advanced ovarian cancer. However neoadjuvant chemotherapy followed by interval debulking is an alternative option, particularly in those who may be poor surgical candidates. OBJECTIVE: The objectiv...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Obstet Gynecol
Autori principali: CHAM, Stephanie, CHEN, Ling, ST. CLAIR, Caryn M., HOU, June Y., TERGAS, Ana I., MELAMED, Alexander, ANANTH, Cande V., NEUGUT, Alfred I., HERSHMAN, Dawn L., WRIGHT, Jason D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545148/
https://ncbi.nlm.nih.gov/pubmed/30771346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2019.02.019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi